Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we have three new pieces of research that affect us in general practice. 

First: What interim anti-coagulation would you give your patient with suspected VTE? One common option has 5 times the rate of major bleeding.

Second: How much muscle mass do people lose with weight loss on GLP1s? Is this different from lifestyle-based interventions, and is there anything patients can do about it?

Third: Why don't we use clinical decision support tools for cancer? This research looks at the barriers and then I over-share my own thoughts on the subject...

References

NEJM Apixaban or rivaroxaban bleeding risk with acute VTE

Diabetes, Obesity & Metabolism Lean mass loss with incretin therapies vs lifestyle interventions

BJGP: Why don't we use clinical decision tools

www.nbmedical.com/podcast